Pectolvan^® Plyush (Syrup) Instructions for Use

Marketing Authorization Holder

Farmak, JSC (Ukraine)

ATC Code

R05CA (Expectorants)

Active Substance

Hederae Helix folia (Grouping name)

Dosage Form

Pectolvan® Plyush

Syrup: bottle 100 ml with dosing spoon

Dosage Form, Packaging, and Composition

Excipients: sodium citrate dihydrate – 12 mg, citric acid monohydrate – 5.3 mg, sorbitol (E420) – 385 mg, potassium sorbate – 1.34 mg, xanthan gum – 1.2 mg, food flavoring “Cherry 667” – 0.125 mg, purified water – up to 1 ml.

100 ml – glass bottles (1) in a cardboard box with a dosing spoon.

Clinical-Pharmacological Group

Herbal preparation with expectorant effect

Pharmacotherapeutic Group

Herbal expectorant

Pharmacological Action

A herbal medicinal product. It has an expectorant, mucolytic, and antispasmodic effect, due to the presence of saponins.

Indications

As an expectorant in the complex therapy of infectious and inflammatory diseases of the respiratory tract, accompanied by cough with difficult-to-discharge sputum.

ICD codes

Dosage Regimen

Administer orally. Use the provided dosing spoon for accurate measurement.

For children aged 2 to 4 years, administer 2.5 ml twice daily.

For children aged 4 to 10 years, administer 2.5 ml three times daily.

For children over 10 years and adults, administer 5 ml three times daily.

Adhere to a minimum of 5-7 days of continuous treatment for therapeutic effect.

Take the syrup independently of meals. Shake the bottle well before each use.

Consume a sufficient amount of warm fluids during treatment to enhance the mucolytic action.

Do not exceed the recommended daily dose. The duration of therapy is determined by the physician based on clinical response.

Discontinue use and consult a physician if symptoms persist or worsen after one week of treatment.

Avoid concomitant use with antitussive medications as this may hinder sputum clearance.

Adverse Reactions

Possible: allergic reactions, nausea, vomiting, diarrhea.

Rarely: pain in the epigastric region.

Contraindications

Hypersensitivity to the product; childhood – depending on the dosage form.

Use in Pregnancy and Lactation

Not recommended for use during pregnancy and lactation.

Pediatric Use

Can be used in children of the appropriate age categories according to indications, in recommended doses and dosage forms. It is necessary to strictly follow the instructions in the leaflets for ivy preparations regarding contraindications for the use of specific dosage forms of this product in children of different ages.

Special Precautions

During treatment, it is recommended to consume a sufficient amount of warm fluids (water, tea, etc.).

If there is no effect after 5-7 days of treatment with the product and/or if the condition worsens (appearance of choking attacks, purulent sputum, fever), it is necessary to consult a doctor.

Drug Interactions

Should not be used simultaneously with antitussive medicinal products, as this impedes the discharge of liquefied sputum.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.